Your browser doesn't support javascript.
loading
Predominance of Atopic Asthma in Patients with Severe or Difficult-to-Treat Asthma in the TENOR-II cohort.
Haselkorn, Tmirah; Mink, David; Kianifard, Farid; Ortiz, Benjamin; Paknis, Brandee; Lecocq, Jason; Chipps, Bradley E; Bleecker, Eugene R.
Afiliação
  • Haselkorn T; EpiMetrix, Inc, Los Altos, California.
  • Mink D; ICON Plc, San Francisco, California.
  • Kianifard F; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey.
  • Ortiz B; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey.
  • Paknis B; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey.
  • Lecocq J; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey.
  • Chipps BE; Capital Allergy and Respiratory Disease Center, Sacramento, California. Electronic address: bchipps@capitalallergy.com.
  • Bleecker ER; Department of Medicine, University of Arizona Health Sciences, Tucson, Arizona.
Ann Allergy Asthma Immunol ; 127(5): 593-595, 2021 11.
Article em En | MEDLINE | ID: mdl-34391902
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Asma / Antiasmáticos / Hipersensibilidade Imediata Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Asma / Antiasmáticos / Hipersensibilidade Imediata Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article